These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 21620130

  • 1. Prognostic factors for hepatocellular carcinoma recurrence: experience with 83 liver transplantation patients.
    Ataide EC, Boin IF, Almeida JR, Sevá-Pereira T, Stucchi RS, Cardoso AR, Caruy CA, Escanhoela CA.
    Transplant Proc; 2011 May; 43(4):1362-4. PubMed ID: 21620130
    [Abstract] [Full Text] [Related]

  • 2. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.
    de Ataide EC, Garcia M, Mattosinho TJ, Almeida JR, Escanhoela CA, Boin IF.
    Transplant Proc; 2012 Oct; 44(8):2438-40. PubMed ID: 23026614
    [Abstract] [Full Text] [Related]

  • 3. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
    Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G.
    Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
    [Abstract] [Full Text] [Related]

  • 4. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT, Woon WA, Tan YM, Lee KH, Tan KC.
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [Abstract] [Full Text] [Related]

  • 5. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [Abstract] [Full Text] [Related]

  • 6. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN.
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [Abstract] [Full Text] [Related]

  • 7. Living donor liver transplantation for hepatocellular carcinoma.
    Isik B, Ince V, Karabulut K, Kayaalp C, Yilmaz S.
    Transplant Proc; 2012 Dec; 44(6):1713-6. PubMed ID: 22841251
    [Abstract] [Full Text] [Related]

  • 8. Late recurrence of hepatocellular carcinoma after liver transplantation: is an active surveillance for recurrence needed?
    Castroagudín JF, Molina-Pérez E, Ferreiro-Iglesias R, Abdulkader I, Otero-Antón E, Tomé S, Varo-Pérez E.
    Transplant Proc; 2012 Dec; 44(6):1565-7. PubMed ID: 22841215
    [Abstract] [Full Text] [Related]

  • 9. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, Rosen M, Soulen M, Shaked A, Reddy KR, Olthoff KM.
    Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM, Kwon CH, Joh JW, Choi MS, Lee JH, Koh KC, Paik SW, Kim GS, Kim SJ, Lee SK, Yoo BC.
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [Abstract] [Full Text] [Related]

  • 11. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH, Walser EM, Paz-Fumagalli R, McKinney JM, May GR.
    Cardiovasc Intervent Radiol; 2007 Mar; 30(5):888-93. PubMed ID: 17619218
    [Abstract] [Full Text] [Related]

  • 12. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program.
    Nemes B, Gelley F, Piros L, Zádori G, Görög D, Fehérvári I, Kóbori L, Sárváry E, Nagy P, Kiss A, Doros A.
    Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108
    [Abstract] [Full Text] [Related]

  • 13. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK.
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [Abstract] [Full Text] [Related]

  • 14. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria.
    Felga G, Evangelista AS, Salvalaggio PR, Curvelo LA, Della Guardia B, Almeida MD, Afonso RC, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
    Shim JH, Lee HC, Han S, Kang HJ, Yu E, Lee SG.
    Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
    [Abstract] [Full Text] [Related]

  • 16. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F, Angele MK, Rentsch M, Graeb C, Gerbes A, Löhrs U, Beuers U, Jauch KW.
    Clin Transplant; 2007 Mar; 21(6):696-701. PubMed ID: 17988261
    [Abstract] [Full Text] [Related]

  • 17. Investigation of histological vascular invasion from preoperative evaluation in patients with hepatocellular carcinoma who underwent living donor liver transplantation.
    Sakai K, Okajima H, Koshino K, Suzuki T, Nobori S, Matsuyama M, Ushigome H, Ochiai T, Yoshimura N.
    Transplant Proc; 2012 Mar; 44(2):409-11. PubMed ID: 22410029
    [Abstract] [Full Text] [Related]

  • 18. Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors.
    Pérez-Saborido B, de los Galanes SJ, Menéu-Díaz JC, Romero CJ, Elola-Olaso AM, Suárez YF, Valencia VB, Moreno-González E.
    Transplant Proc; 2007 Sep; 39(7):2304-7. PubMed ID: 17889172
    [Abstract] [Full Text] [Related]

  • 19. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
    Moon JI, Kwon CH, Joh JW, Choi GS, Jung GO, Kim JM, Shin M, Choi SJ, Kim SJ, Lee SK.
    Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
    [Abstract] [Full Text] [Related]

  • 20. Effects of risk factors and Ki-67 on rates of recurrence on patients who have undergone liver transplant for hepatocellular carcinoma.
    Aktas S, Karakayali H, Moray G, Ozdemir H, Haberal M.
    Transplant Proc; 2011 Dec; 43(10):3807-12. PubMed ID: 22172851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.